Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Carrascosa

Showing results (211-220 of 242) with videos related to

Pageof 25
Sort By:
The Australasian Journal of Dermatology|July 12, 2023
Effectiveness and safety of brodalumab in the treatment of plaque, scalp and palmoplantar psoriasis: A multicentre retrospective study in a Spanish populationA Sahuquillo-Torralba, M Hospital-Gil, E Vilarrasa-Rull, et al.
Actas Dermo-Sifiliograficas|September 24, 2016
Management of Biologic Therapy in Moderate to Severe Psoriasis in Surgical Patients: Data From the Spanish Biobadaderm RegistryS Galiano Mejías, G Carretero, C Ferrandiz, et al.
Actas Dermo-Sifiliograficas|September 11, 2013
Spanish evidence-based guidelines on the treatment of psoriasis with biologic agents, 2013. Part 1: on efficacy and choice of treatment. Spanish Psoriasis Group of the Spanish Academy of Dermatology and VenereologyL Puig, J M Carrascosa, G Carretero, et al.
Contact Dermatitis|November 16, 2018
Sensitization to fragrances in Spain: A 5-year multicentre study (2011-2015)Juan F Silvestre, Pedro Mercader, Ricardo González-Pérez, et al.
Actas Dermo-Sifiliograficas|June 12, 2018
Description of Patients Treated with Biologic Drugs as First-Line Systemic Therapy in the BIOBADADERM Registry Between 2008 and 2016G Carretero Hernández, C Ferrándiz, R Rivera Díaz, et al.
American Journal of Clinical Dermatology|March 31, 2021
Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort StudyTiago Torres, Luis Puig, Ron Vender, et al.
Actas Dermo-Sifiliograficas|May 8, 2022
Epidemiological, Clinical, and Allergy Profile of Patients With Atopic Dermatitis and Hand Eczema: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC)V Mora-Fernández, P Mercader Garcia, L Borrego Hernando, et al.
Actas Dermo-Sifiliograficas|October 15, 2020
Changing Trends in Drug Prescription and Causes of Treatment Discontinuation of First Biologic Over Ten Years in Psoriasis in the Spanish Biobadaderm RegistryD P Ruiz-Genao, G Carretero, R Rivera, et al.
Contact Dermatitis|February 3, 2021
Frequency of sensitization to the individual fragrances of fragrance mix I and II according to the factors included in the MOAHLFA indexMaría J Sánchez-Pujol, Alexandre Docampo-Simón, Pedro Mercader, et al.
Acta Dermato-Venereologica|December 3, 2020
Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective CohortCarlos Pelayo Hernández-Fernández, Gregorio Carretero, Raquel Rivera, et al.
Pageof 25

Showing results (211-220 of 242) with videos related to

Sort By:
Pageof 25
The Australasian Journal of Dermatology|July 12, 2023
Effectiveness and safety of brodalumab in the treatment of plaque, scalp and palmoplantar psoriasis: A multicentre retrospective study in a Spanish populationA Sahuquillo-Torralba, M Hospital-Gil, E Vilarrasa-Rull, et al.
Actas Dermo-Sifiliograficas|September 24, 2016
Management of Biologic Therapy in Moderate to Severe Psoriasis in Surgical Patients: Data From the Spanish Biobadaderm RegistryS Galiano Mejías, G Carretero, C Ferrandiz, et al.
Actas Dermo-Sifiliograficas|September 11, 2013
Spanish evidence-based guidelines on the treatment of psoriasis with biologic agents, 2013. Part 1: on efficacy and choice of treatment. Spanish Psoriasis Group of the Spanish Academy of Dermatology and VenereologyL Puig, J M Carrascosa, G Carretero, et al.
Contact Dermatitis|November 16, 2018
Sensitization to fragrances in Spain: A 5-year multicentre study (2011-2015)Juan F Silvestre, Pedro Mercader, Ricardo González-Pérez, et al.
Actas Dermo-Sifiliograficas|June 12, 2018
Description of Patients Treated with Biologic Drugs as First-Line Systemic Therapy in the BIOBADADERM Registry Between 2008 and 2016G Carretero Hernández, C Ferrándiz, R Rivera Díaz, et al.
American Journal of Clinical Dermatology|March 31, 2021
Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort StudyTiago Torres, Luis Puig, Ron Vender, et al.
Actas Dermo-Sifiliograficas|May 8, 2022
Epidemiological, Clinical, and Allergy Profile of Patients With Atopic Dermatitis and Hand Eczema: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC)V Mora-Fernández, P Mercader Garcia, L Borrego Hernando, et al.
Actas Dermo-Sifiliograficas|October 15, 2020
Changing Trends in Drug Prescription and Causes of Treatment Discontinuation of First Biologic Over Ten Years in Psoriasis in the Spanish Biobadaderm RegistryD P Ruiz-Genao, G Carretero, R Rivera, et al.
Contact Dermatitis|February 3, 2021
Frequency of sensitization to the individual fragrances of fragrance mix I and II according to the factors included in the MOAHLFA indexMaría J Sánchez-Pujol, Alexandre Docampo-Simón, Pedro Mercader, et al.
Acta Dermato-Venereologica|December 3, 2020
Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective CohortCarlos Pelayo Hernández-Fernández, Gregorio Carretero, Raquel Rivera, et al.
Pageof 25